To investigate the risk factors involved in the occurrence and prognosis of the patients with acute coronary syndrome, patients undergoing percutaneous coronary intervention will be recruited and followed up for at least 2 years.
Diagnosed as acute coronary syndrome and needed to undergo percutaneous coronary intervention.
>18 years old.
With malignant tumors, acute infectious diseases and advanced liver diseases.
Won't sign an inform consent.
Patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Cohort
Prospective
Not listed
major adverse cardiovascular events
all-cause mortality, cardiovascular mortality, ischemic stroke
Click on the lead sponsor to view all of their trials.
Su Guohai
Lead sponsor
Jinan Central Hospital
Sponsor institution
Shandong First Medical University
Collaborator
